Still, doctors in nursing homes across Texas continue to prescribe the drug to dementia patients like Jessie to calm them down.
Target dementia patients, federal court records show.
From the late 1990’s to 2004, sales reps made thousands of calls promoting the drug “as safe and effective” for treating “behavior problems” in elderly dementia patients, court documents show.
The company paid a $158 million settlement in Texas after it was accused of improperly marketing Risperdal to state residents.
It was the largest U.S. settlement involving marketing of antipsychotic drugs to older dementia patients, and the third largest health care fraud settlement in U.S. history.